Is GSK prepping a $1bn takeover bid for IDRx? | pharmaphorum
1 day ago · GSK is reportedly in late-stage negotiations about a $1 billion deal to acquire IDRx and its experimental targeted therapy for a form of rare gastrointestinal stromal tumour (GIST). …
GSK is said to be nearing $1B deal to acquire U.S. biotech IDRx
British pharma giant GSK (NYSE:GSK) is closing in on a $1B buyout deal to acquire IDRx, a U.S. biotech focused on developing drugs for rare gastrointestinal tumors, The Financial Times …
GSK in Talks to Buy U.S. Rare Tumor Specialist IDRx for up to $1 ...
1 day ago · --Pharmaceutical giant GSK PLC is in talks to buy U.S. privately owned biotech company IDRx, which is developing a treatment for rare gastrointestinal tumors, for up to $1 …
GSK in advanced talks to purchase U.S. biotech IDRx, FT reports
2 days ago · GSK is in advanced discussions to purchase privately-owned U.S. biotech IDRx, which is working on a treatment for rare gastrointestinal tumors, the Financial Times’ Oliver …
GSK Nears $1 Billion Deal for Biotech Company IDRx
1 day ago · GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio.
GSK nears $1bn deal for biotech developing drug for rare tumour
1 day ago · GSK nears $1bn deal for biotech developing drug for rare tumour. ... Portfolio FT App FT Digital Edition FT Edit Alerts Hub Business School Rankings Subscription Manager News …
GSK Nearing Deal to Acquire US Biotech IDRx for Up to $1 Billion
1 day ago · -- GSK is in advanced discussions to acquire privately-owned US biotech company IDRx for up to $1 billion, the Financial Times reported Wednesday, citing people close to the …
GSK in talks to buy US biotech company for $1bn
1 day ago · The FTSE 100 company plans the bolt-on purchase of IDRx, a cancer drug specialist based in Cambridge, Massachusetts
GSK swooping to buy US biotech IDRx for $1bn - report
1 day ago · UK pharma giant GSK PLC is close to buying US biotech startup IDRx for $1 billion to boost its cancer drug business, the Financial Times has reported. Backed by a raft of venture …
GSK nears $1B deal to buy U.S. biotech IDRx (GSK:NYSE)
1 day ago · GSK is said to be nearing $1B deal to acquire U.S. biotech IDRx Jan. 08, 2025 10:19 AM ET GSK plc (GSK) Stock BX By: Dulan Lokuwithana , SA News Editor Play ( 2min )
- Some results have been removed